At ASH 2018, Dr. Nabhan discusses his change from 20 years of directly caring for patients and doing interventional research to working for Cardinal Health in the space between drug manufacturers and prescribing hematologists and oncologists.
- There are more important research answers to be found besides what can be discovered in even a well-designed clinical trial.
- Real world data tells us about the experience in the clinic, outside the academic centers and this is where most patients get their care.
- Patient reported outcomes (PROs) are supposed to be a greater part of research, but their uptake in clinical trials has been painfully slow.
- Economic factors are often the elephant in the room that are under discussed in research.
This is personal. This ASH 2018 interview was therapeutic for me.
Dr. Nabhan left direct patient care in 2016 as I did in 2018.
It was tough. Both of us agree that nothing will ever replace being with a patient, answering their questions, helping them move beyond the problem they are facing.
But we can still make a difference even if we no longer sport a stethoscope. We can do research that changes how diseases are treated for the better. We can inform and guide a group of patients towards their best care. We can still care for a cohort if not an individual.
But I will always miss the personal care of family medicine.
Here is my interview with Dr. Nabhan.